Decipher Labs Ltd (BSE: 524752) is a Hyderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹6 Cr, it ranks #5,326 by market cap among the 6,137 Indian listed companies on FinBizNet, and #86 of 86 in Medicinal Chemicals and Botanical Products. At ₹5.08 (as of 25 Oct 2026), the share price is 53.8% below its 52-week high of ₹10.99 and 5.6% above its 52-week low of ₹4.81. The share price is down 47.5% over one year and down 14.6% over three months.
| Current Price | ₹5.08 |
|---|---|
| Market Cap | ₹6 Cr |
| BSE Code | 524752 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | -1.8 |
| Return on Equity | -14.17% |
| Return on Assets | -8.74% |
| 52-Week Range | ₹4.81 – ₹10.99 |
| 1-Year Price Change | -47.5% |
| 3-Month Price Change | -14.6% |
| Beta (1Y) | 0.92 |
| Headquarters | Hyderabad, Telangana |
| Website | decipherlabs.in |
Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through Pharmaceutical and Consultancy segments. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.
1. Manufacturing and Trading of Pharmaceutical Drugs-This segment engages in the manufacture, sale, and export of pharmaceutical formulations and customized non-sterile products in India. Its product line comprises tablets, capsules, ointments, and liquid orals. 2. Consultancy Services-This segment provides consultancy services. 3. Segment Adjustment-0
1. Pharma-4.8% 2. Consultancy Services-95.2%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Decipher Labs Ltd | ₹6 Cr | -1.8 | -14.17% | — | -47.5% |
Listed by market capitalisation. Ratios are shown for context only.
Decipher Labs Ltd is trading at ₹5.08, with a market capitalisation of ₹6 Cr.
Decipher Labs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Decipher Labs Ltd has a P/E of -1.8 and a return on equity of -14.17%.
Decipher Labs Ltd is listed on the BSE under the scrip code 524752.
Decipher Labs Ltd's share price is down 47.5% over one year and down 14.6% over three months. Its 52-week range is ₹4.81 to ₹10.99.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.